Concepedia

Dagmar Trummel

DT

2

Publications

96

Citations

2

H-Index

2018

Active since

Affiliations

Bayer (Germany)(Current)

Dagmar Trummel is an author at Bayer (Germany) specializing in pre-clinical pharmacology, health sciences, and neuropharmacology.

Top concepts

HealthMedicinePharmacologyEndocrinologyPharmacotherapyNeuropharmacologyClinical PharmacologyMolecular PharmacologyPre-clinical PharmacologyUrology

Publications per year

2018–2019

2

Publications

2

Higher blood–brain barrier penetration of [<sup>14</sup>C]apalutamide and [<sup>14</sup>C]enzalutamide compared to [<sup>14</sup>C]darolutamide in rats using whole-body autoradiography.

Christian Zurth, Steffen Sandman, Dagmar Trummel et al. · Journal of Clinical Oncology · 2019 · 51 citations

Moderate Bbb Penetration, Pharmacotherapy, Experimental Pharmacology +22

Blood-brain barrier penetration of [14C]darolutamide compared with [14C]enzalutamide in rats using whole body autoradiography.

Christian Zurth, Steffen Sandmann, Dagmar Trummel et al. · Journal of Clinical Oncology · 2018 · 45 citations

Pain Medicine, Pharmacotherapy, Experimental Pharmacology +21

Rows per page

1–2 of 2